Gonzales v. Raich — Commerce Clause & Drug Regulation

Gonzales v. Raich, 545 U.S. 1 (2005), is the Supreme Court's 6-3 decision upholding the federal Controlled Substances Act as applied to homegrown marijuana cultivated for personal medical use in California — even though the marijuana never crossed a state line, was never sold, and was grown entirely within the state under explicit California authorization. Angel Raich and Diane Monson were California patients who grew or obtained cannabis for severe medical conditions under California's 1996 Compassionate Use Act. When federal Drug Enforcement Administration agents destroyed Monson's marijuana plants, Raich and Monson sued, arguing that the federal Controlled Substances Act exceeded congressional Commerce Clause authority as applied to purely intrastate, non-commercial medical marijuana use. Justice Stevens's majority opinion rejected this argument and applied Wickard v. Filburn (1942): even if Raich and Monson's individual cultivation was purely local and non-commercial, Congress could rationally conclude that permitting home cultivation of marijuana — in the aggregate across all similarly situated patients — would substantially undermine the federal drug control scheme by creating a licit local supply that could leak into the illicit interstate market. Raich is the most important Commerce Clause case since Wickard and effectively defines the outer limit of United States v. Lopez (1995): the economic/non-economic distinction that limits Congress's power does not reach the production and consumption of commodities, even locally, when those commodities are part of a comprehensive interstate market regulation.

Current Law (2026)

Legal Authority

• U.S. Const. art. I, § 8, cl. 3 — "The Congress shall have Power . . . To regulate Commerce with foreign Nations, and among the several States, and with the Indian Tribes"
• U.S. Const. art. I, § 8, cl. 18 — Necessary and Proper Clause — Congress may use any means plainly adapted to a legitimate end; Raich held that regulating home cultivation is necessary and proper to the federal drug control scheme
• 21 U.S.C. § 801 — Controlled Substances Act findings: Congress's express findings that local drug activities substantially affect interstate commerce; used in Raich as evidence of the rational basis for the CSA's application
• 21 U.S.C. § 812 — CSA Schedule classifications; marijuana listed as Schedule I (high abuse potential, no accepted medical use, lack of accepted safety) — the classification at issue in Raich
• 21 U.S.C. § 841 — CSA prohibition on manufacture, distribution, or possession with intent to distribute controlled substances; applied to Monson's plants by DEA
• Gonzales v. Raich, 545 U.S. 1 (2005) — Comprehensive federal drug regulation of marijuana sustained under Commerce Clause/N&P Clause; Wickard applied to marijuana home cultivation; Lopez confined to non-economic activity
• Wickard v. Filburn, 317 U.S. 111 (1942) — Aggregate effects doctrine; home-grown wheat; the direct doctrinal predecessor Stevens explicitly applied in Raich
• United States v. Lopez, 514 U.S. 549 (1995) — Commerce Clause limits; Raich distinguished Lopez by holding that marijuana cultivation is economic activity

Key Mechanics

Gonzales v. Raich (2005) arose when DEA agents destroyed marijuana plants that California residents Angel Raich and Diane Monson were growing under California's Compassionate Use Act for personal medical use — never sold, never crossing state lines. The Ninth Circuit held that the Commerce Clause did not support applying the Controlled Substances Act to purely intrastate, non-commercial cultivation. The Supreme Court reversed 6-3 in an opinion by Justice Stevens. The Court applied Wickard v. Filburn's aggregate-effects doctrine: even though each individual plant never entered interstate commerce, home cultivation of marijuana, taken in the aggregate across all similarly situated growers, substantially affects the interstate market for marijuana — because home-grown marijuana substitutes for market purchases and undermines the federal regulatory scheme designed to eliminate that market. The Necessary and Proper Clause further supported the application: Congress could rationally conclude that excluding home-grown marijuana from CSA regulation would undercut the entire schedule of federal drug controls. Justice O'Connor's dissent warned that this reading of Wickard effectively eliminates any meaningful limit on the Commerce Clause after Lopez and Morrison. Raich remains good law and is the primary precedent supporting broad federal authority over activities that, while local, are part of larger economic markets that Congress has regulated.

How It Works

Angel Raich and Diane Monson

Angel Raich suffered from a diagnosed constellation of serious medical conditions — an inoperable brain tumor, scoliosis, life-threatening wasting syndrome, nausea, and severe chronic pain. She had tried approximately thirty conventional treatments without adequate relief; her physician recommended cannabis as potentially life-saving. Diane Monson, a California resident, suffered from severe back pain and muscle spasms for which cannabis provided relief she could not find in conventional medicine. Both women complied with California's Compassionate Use Act, which authorized physicians to recommend cannabis to seriously ill patients. Monson grew her own plants at home; Raich obtained cannabis from caregivers who grew it without charge.

On August 15, 2002, county sheriff's deputies inspected Monson's property and confirmed she was in compliance with California law. Federal DEA agents nonetheless arrived later the same day and destroyed her six cannabis plants. Raich and Monson filed suit under the Administrative Procedure Act and the Fifth Amendment, seeking an injunction against future federal enforcement.

The Ninth Circuit's Decision

The Ninth Circuit held in favor of Raich and Monson: the CSA as applied to intrastate, non-commercial, medical marijuana use exceeded Congress's Commerce Clause authority under Lopez and United States v. Morrison (2000). The Ninth Circuit reasoned that the plaintiffs' purely local, non-commercial medical marijuana use — which never entered any market — was not economic activity and could not be regulated under the aggregate effects doctrine.

The Supreme Court reversed.

Stevens's Majority: Wickard Controls Economic Commodity Production

Justice Stevens's majority opinion (joined by Kennedy, Souter, Ginsburg, and Breyer, with Scalia concurring separately in the judgment) began with Wickard v. Filburn as the controlling precedent. Wickard had held that Congress could regulate wheat grown entirely on a farm for home consumption because, in the aggregate across all similarly situated farmers, home-grown wheat substantially affected the interstate wheat market. The only question in Raich was whether the same logic applied to marijuana.

Marijuana cultivation is economic activity: Stevens rejected the Ninth Circuit's characterization of the plaintiffs' activities as non-economic. The production, distribution, and consumption of commodities — whether wheat or marijuana — is quintessentially economic. Unlike the gun possession in Lopez (not itself a commercial transaction) or the gender-motivated violence in Morrison (not itself economic activity), growing and consuming a marketable plant is economic activity in the same category as Filburn's wheat. The economic/non-economic distinction that Lopez introduced does not reach commodity production.

The comprehensive regulatory scheme: The CSA is a comprehensive regulatory scheme for controlling an established interstate market in controlled substances. It regulates the production, distribution, manufacture, and possession of hundreds of substances. Congress's regulatory choice — total prohibition of marijuana as a Schedule I substance — requires that all marijuana supplies be controlled, including home-grown supplies. If home cultivation is excluded from the regulatory scheme, patients like Raich and Monson could substitute home-grown for market-purchased marijuana; the total supply of marijuana not under federal control would expand; and the price and availability of marijuana in the interstate market could be affected.

More fundamentally, a licit local market in home-grown marijuana — even if individually small — would create supply that could leak into the illicit interstate market. Without the ability to control local cultivation, the federal government could not effectively control the interstate market it has chosen to regulate. The Necessary and Proper Clause independently supports Congress's authority: regulating home cultivation is a necessary and proper means of effectuating a comprehensive drug control scheme.

Rational basis deference: Under Wickard's framework, the question is only whether Congress had a rational basis to conclude that the regulated class of activities — home cultivation of marijuana — in the aggregate substantially affects interstate commerce. Congress's CSA findings (21 U.S.C. § 801) documented the interstate dimension of the drug trade. The rational basis standard, applied deferentially, is readily satisfied.

Scalia's Concurrence: The Necessary and Proper Emphasis

Justice Scalia concurred in the judgment but wrote separately to ground the holding primarily in the Necessary and Proper Clause rather than the substantial effects test. Scalia argued that local marijuana cultivation is not itself "commerce among the several States" in any sense — it is neither a channel, instrumentality, nor direct substantial effect. But Congress can regulate it under the Necessary and Proper Clause as a means plainly adapted to its legitimate goal of controlling the interstate drug market. The N&P Clause allows Congress to regulate even non-interstate activity when doing so is necessary to make a larger interstate regulation work.

Scalia's concurrence is notable because it provides a potential framework for federal power that does not require finding that purely local activity itself "substantially affects" interstate commerce — instead, the question is whether regulating the local activity is necessary to an otherwise valid interstate regulatory scheme. This framing has broader implications for Commerce Clause doctrine.

The Dissents: O'Connor, Rehnquist, and Thomas

Justice O'Connor's dissent (joined by Chief Justice Rehnquist and Justice Thomas in part) argued that Raich effectively swallowed Lopez and Morrison whole. If Congress can regulate any local economic activity that is part of a class of activities that substantially affects interstate commerce, there is no meaningful limiting principle left from Lopez. O'Connor emphasized the states' role in the federal structure — California had made a carefully considered judgment about medical marijuana, and federal law displaced that judgment entirely.

Justice Thomas's dissent went further, arguing that Wickard's aggregate effects doctrine was itself wrong: "Wickard, which is perhaps the most far-reaching example of Commerce Clause authority over intrastate activity, is today eclipsed." If anything that is part of a larger economic market can be regulated, the Commerce Clause has no meaningful limit.

The dissenters emphasized the California context: Raich and Monson were engaged in activities entirely within California, explicitly authorized by California law, with no commercial element. If this falls within Commerce Clause authority, it is hard to identify what local activity does not.

What Raich Means for Cannabis Federalism

Raich's most immediate and enduring consequence is for cannabis law. The decision confirmed that the Controlled Substances Act's prohibition of marijuana is constitutionally valid under the Commerce Clause — regardless of state law. Every state marijuana legalization law (recreational or medical) operates in the constitutional shadow of Raich: the federal government retains the constitutional authority to prosecute any marijuana activity, even state-legal activity.

This creates the paradox of cannabis federalism. As of 2026, recreational marijuana is legal in twenty-four states plus D.C.; comprehensive medical marijuana programs exist in roughly thirty-eight states plus D.C., with several additional states authorizing only narrow CBD or low-THC products. But the CSA classifies marijuana as Schedule I, and Raich confirms this is constitutional. The practical accommodation is federal enforcement discretion — the Obama, Biden, and (partially) Trump administrations have generally deprioritized prosecution of state-legal cannabis activities — but this discretion can change with any new administration. The constitutional authority exists at all times.

Federal cannabis prohibition under Raich's constitutional authorization produces cascading consequences even when federal prosecutions are rare: cannabis businesses in legal states cannot access federal bankruptcy courts; federal banking law creates de facto cash-only businesses (banks fear federal prosecution); federal employees and security clearance holders cannot use cannabis without risking their employment; federal housing assistance recipients are prohibited from using cannabis; and interstate transportation of cannabis remains federal criminal conduct even between legal states.

Raich and the Economic Activity Boundary

Raich establishes a clear doctrinal rule: Lopez's economic/non-economic distinction does not reach commodity production and consumption. The following remain good law under the Lopez/Morrison/Raich synthesis:

Within Commerce Clause authority: Production, manufacture, distribution, sale, or possession of any commodity — including for personal use — when Congress has comprehensively regulated the interstate market for that commodity. Home cultivation of marijuana (Raich). Home production of wheat (Wickard). Any activity that constitutes participation in an economic market, even locally.

Outside Commerce Clause authority: Non-economic activities — possessing a gun near a school (Lopez); gender-motivated violence (Morrison). Activities where the connection to interstate commerce depends on multi-step causal chains attenuated from any commercial transaction.

Compelled economic activity: NFIB v. Sebelius (2012) added the category of inactivity as beyond Commerce Clause reach — Congress cannot compel someone to enter a market.

How It Affects You

If you are a cannabis business owner or operator in a legal state: Raich establishes that your operations, however clearly authorized by state law, exist within the federal government's constitutional authority to prosecute. The practical consequence is not constant federal prosecution — enforcement discretion has generally protected state-legal businesses — but a set of persistent structural disadvantages. Federal bankruptcy is unavailable because cannabis remains a controlled substance; the IRS disallows ordinary business deductions under 26 U.S.C. § 280E for cannabis businesses; federal banking charters cannot serve cannabis businesses without risk; and your products cannot cross state lines without federal criminal exposure. Any change in administration priorities could expose your operations to federal action. The constitutional authority Raich confirmed means that only a legislative change to the CSA — not a court ruling — can resolve these structural problems.

If you are a cannabis patient using state-legal medical marijuana: Raich means that your state-authorized medical use has no federal constitutional protection. Federal law classifies the cannabis you use as a Schedule I controlled substance, and Raich confirmed Congress's authority to criminalize your cultivation or possession. Federal prosecution of medical marijuana patients has been rare under executive enforcement policies, but you remain subject to federal law: federal employees and contractors may be fired for cannabis use; housing assistance recipients risk loss of benefits; federal benefits programs (Social Security, Medicare, Medicaid) impose no cannabis use restriction but adjacent federal programs do. The DEA's 2024 proposal to reclassify cannabis to Schedule III would substantially change the legal landscape — Schedule III substances can have accepted medical uses and are subject to less severe penalties — but would not eliminate the federal prohibition framework.

If you are a state legislator or governor in a cannabis-legal state: Your state's cannabis legalization framework operates on federal constitutional tolerance, not federal constitutional protection. Raich confirmed Congress's authority to preempt your state's law entirely; the practical reason federal preemption has not occurred is political, not constitutional. This means federal policy changes — a new administration's enforcement priorities, a congressional act, a DEA rescheduling or de-scheduling decision — can fundamentally alter the operating environment for your state's cannabis industry overnight. State legislators interested in protecting the cannabis industry should focus on federal legislative solutions: the SAFE Banking Act (federal banking access), STATES Act (federal non-preemption of state cannabis law), and CSA descheduling proposals all address the Raich constitutional problem at its source.

If you are a federal agency official or constitutional litigant: Raich establishes that comprehensive federal regulation of an interstate commodity market — drugs, agriculture, financial instruments — can validly reach all activity in that market, including purely local production for personal use. The key test is whether the regulated activity is economic in nature (production, distribution, consumption of a commodity) and whether regulating it is rationally necessary to the comprehensive scheme. For regulatory drafting, Raich provides broad authority: the Controlled Substances Act model — comprehensive scheduling, prohibition, and enforcement mechanisms for a commodity market — is constitutionally sustainable. Post-Raich challenges to federal drug, agricultural, or commodity regulation under Commerce Clause grounds face steep odds unless the regulated activity is genuinely non-economic (not a commodity market transaction in any form).

State Variations

Raich defines the constitutional floor of federal power; state variation reflects states' decisions about how much to legalize within the federal constitutional framework — not challenges to federal authority.

Recreational marijuana (24 states + D.C.): Colorado (2012), Washington (2012), California (2016), and many others have legalized recreational cannabis through ballot initiatives or legislation. These state laws permit adult possession, cultivation, and commercial sale. Raich confirms the federal constitutional authority to override these laws; the practical accommodation is federal non-enforcement of state-legal activities. Businesses operating in recreational markets face all of the federal disadvantages noted above.

Medical marijuana (~38 states with comprehensive programs, plus several CBD/low-THC-only states): Most states have medical marijuana programs of varying scope — some comprehensive (California, Colorado), others narrowly limited to CBD products or specific conditions (Texas, Alabama). The constitutional analysis under Raich is identical for all of them.

No-cannabis states: A handful of states — Idaho, Wyoming, South Dakota (recreational), Kansas, and others — have maintained general prohibition consistent with federal law. In these states, there is no state-federal tension; the CSA applies without complication.

State banking accommodations: Several states have created state-chartered cannabis banking programs or "cannabis deposit facilities" to address the federal banking problem Raich enables. These state programs provide some relief but cannot resolve the core federal regulatory risk that prevents federally insured banks from providing services.

Interstate cannabis compacts: Some states have explored interstate cannabis compacts — agreements to allow cannabis to cross state lines between legal states. These are constitutionally constrained: Congress has not authorized such interstate movement (and Raich confirms it could prevent it), and Article I, Section 10 generally requires congressional consent for interstate compacts of this kind.

Pending Legislation

• SAFE Banking Act: Would protect federally regulated financial institutions that provide services to state-legal cannabis businesses from federal prosecution. Has passed the House multiple times; not enacted in the Senate. Would address one of the major practical consequences of Raich's constitutional holding.
• STATES Act: Would amend the CSA to provide that federal cannabis law does not apply in states that have legalized cannabis for medical or recreational use — essentially creating a federal non-preemption rule. Would limit the enforcement scope of the constitutional authority Raich confirmed. Not enacted.
• DEA Cannabis Rescheduling: In 2024, the DEA proposed rescheduling marijuana from Schedule I to Schedule III under the CSA. Schedule III reclassification would not de-schedule cannabis (federal prohibition would continue), but would recognize accepted medical use, reduce penalty severity, and potentially allow 280E tax deductions for cannabis businesses. Raich's constitutional holding would be unaffected — Congress would still have Commerce Clause authority over marijuana in any schedule. As of 2026, the rescheduling process was ongoing.
• CAOA / Marijuana Opportunity Reinvestment and Expungement (MORE) Act: Comprehensive de-scheduling proposals have been introduced, which would remove cannabis from the CSA entirely. If enacted, the regulatory landscape would fundamentally change; federal prohibition would end, and the banking, tax, and enforcement barriers would fall. Raich's constitutional holding would become moot for marijuana, though the precedent establishing Commerce Clause authority over commodity production would remain.

Recent Developments

• 2018 — Murphy v. National Collegiate Athletic Ass'n: The Supreme Court struck down the Professional and Amateur Sports Protection Act (PASPA), which had prohibited states from authorizing sports betting, under the anti-commandeering doctrine. Murphy has been compared to Raich: both involve federal attempts to control activities states wish to legalize. Murphy limits Congress's ability to prohibit states from legalizing activities but does not affect federal authority to directly prohibit those activities itself — the constitutional distinction Raich illustrates.
• 2022 — State recreational legalization wave: Missouri, Maryland, and Arkansas held ballot initiatives on recreational cannabis; Missouri and Maryland approved. The continued state legalization movement has not altered Raich's constitutional holding but has intensified political pressure for federal reform.
• 2024 — DEA cannabis rescheduling: The DEA initiated formal rulemaking to reschedule marijuana from Schedule I to Schedule III — a significant policy shift within the federal regulatory framework that Raich confirmed Congress has authority to create. A hearing before a DEA administrative law judge was scheduled for late 2024; the rescheduling process continued under the incoming Trump administration.
• 2025 — Federal enforcement policy: The second Trump administration's approach to cannabis enforcement generated significant uncertainty for the state-legal cannabis industry. The administration's posture on federal enforcement against state-legal operations — and its position on the pending rescheduling proceeding — remained key variables for the industry as of 2026.
• 2025 — SAFE Banking Act stalled: Despite strong bipartisan support in multiple sessions, the SAFE Banking Act had not been enacted as of 2026, leaving cannabis businesses without federal banking access. The Senate filibuster and competing legislative priorities had repeatedly blocked the bill despite House passage.